Clear objectives, proper planning, change management, adequate resources, and ongoing maintenance can lead to better outcomes for your LIMS...
Phage display has become an invaluable tool for the discovery of novel therapeutic agents, including nanobodies.
In the fight against infectious diseases, scientists are continually seeking to outsmart pathogens. One such strategy involves the use of nanobodies.
StackWave Affinity v16 Announcement - Next Generation Sequencing
An emerging therapeutic strategy to tackle cancer is nanobodies – small, single-domain antibody fragments derived from heavy-chain-only antibodies.
Bulk B cell analysis is a powerful tool for antibody discovery because it provides a snapshot of the entire B cell population at a given time.
ADCs are essentially a new class of drugs that combine the targeting properties of antibodies with the cell-killing ability of drugs.
Monoclonal antibodies are revolutionizing therapeutics with their precision and specificity, allowing for safer treatment of a variety of diseases...
StackWave Affinity v15 Announcement - Titration and Dose Response Experiments
We are excited to announce the release of StackWave Affinity™ v13! Highlights include integrated ELN and nanobody support.